Lee Ainslie - Maverick Capital
Holding/activity history for Nektar Therapeutics (NKTR)
← All NKTR superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 0.30 | $44.40–77.70 · VW $57.35i | SEC | |
| 2022 Q2 | 214,559 | 0.30 | Reduce 32.85% | 0.15 | $45.30–93.90 · VW $62.23i | $12,230,000 | SEC |
| 2022 Q1 | 319,528 | 0.47 | Reduce 17.68% | 0.16 | $58.20–210.90 · VW $130.99i | $25,834,000 | SEC |
| 2021 Q4 | 388,174 | 0.89 | Reduce 0.27% | <0.01 | $158.85–280.35 · VW $206.07i | $78,663,000 | SEC |
| 2021 Q3 | 389,228 | 1.06 | Add 1.34% | 0.01 | $193.80–290.55 · VW $243.94i | $104,858,000 | SEC |
| 2021 Q2 | 384,072 | 0.94 | Reduce 1.66% | 0.02 | $239.55–313.50 · VW $274.38i | $98,860,000 | SEC |
| 2021 Q1 | 390,554 | 1.07 | Reduce 11.98% | 0.22 | $246.15–401.25 · VW $319.26i | $117,166,000 | SEC |
| 2020 Q4 | 443,708 | 1.81 | Add 17.21% | 0.27 | $231.00–291.90 · VW $255.14i | $113,146,000 | SEC |
| 2020 Q3 | 378,548 | 1.75 | Add 9.48% | 0.15 | $246.15–375.90 · VW $301.75i | $94,202,000 | SEC |
| 2020 Q2 | 345,776 | 2.53 | Add 5.88% | 0.14 | $249.00–359.40 · VW $311.17i | $120,123,000 | SEC |
| 2020 Q1 | 326,560 | 1.85 | Add 51.13% | 0.63 | $204.45–429.00 · VW $312.25i | $87,436,000 | SEC |
| 2019 Q4 | 216,082 | 1.02 | Buy | 1.02 | $234.60–349.80 · VW $284.23i | $69,962,000 | SEC |
| 2005 Q1 | 0 | 0.00 | Sell 100.00% | 0.69 | $199.80–308.55 · VW $246.48i | SEC | |
| 2004 Q4 | 164,832 | 0.69 | Buy | 0.69 | $204.90–309.30 · VW $267.22i | $50,043,000 | SEC |